Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026)

Integer Holdings (ITGR) reported Liabilities and Shareholders Equity of $3.4 billion for Q2 2026, up 3.46% on a YoY basis from $3.3 billion in Q2 2025, and little changed sequentially from $3.4 billion in Q4 2025.

Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Integer Holdings (ITGR) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $3.4 billion in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 3.46% year-over-year to $3.4 billion; the trailing twelve-month figure through Apr 2026 stood at $13.6 billion (up 7.27% YoY), and the FY2025 full-year result was $3.4 billion, up 10.81% from the prior year.
  • Liabilities and Shareholders Equity was little changed at $3.4 billion in Q2 2026, from $3.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.4 billion in Q2 2026 to a low of $2.6 billion in Q2 2022.
  • A 5-year average of $3.0 billion and a median of $3.1 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity gained 16.91% in 2022 and advanced 3.46% in 2026, its largest moves.
  • Tracing ITGR's Liabilities and Shareholders Equity over 5 years: stood at $2.8 billion in 2022, then gained by 5.31% to $2.9 billion in 2023, then grew by 4.6% to $3.1 billion in 2024, then advanced by 10.81% to $3.4 billion in 2025, then gained by 0.03% to $3.4 billion in 2026.
  • Business Quant data shows ITGR's Liabilities and Shareholders Equity at $3.4 billion in Q2 2026, $3.4 billion in Q4 2025, and $3.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 180.89 Bn 173.59 Bn 6.27 Bn 110.43 Bn
2 Stryker 127.82 Bn 124.94 Bn 3.81 Bn 46.29 Bn
3 Medtronic 107.49 Bn 98.27 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 67.24 Bn 65.78 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.02 Bn 44.34 Bn 1.29 Bn 13.32 Bn
6 Dexcom 28.25 Bn 27.14 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 28.17 Bn 25.89 Bn 1.98 Bn 37.13 Bn
8 Smith & Nephew 26.72 Bn 26.14 Bn - 10.46 Bn
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn 31.92 Bn
10 Integer Holdings 3.39 Bn 3.38 Bn 109.60 Mn 3.41 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 3.41 Bn
Dec 31, 2025 3.41 Bn
Sep 26, 2025 3.40 Bn
Jun 27, 2025 3.37 Bn
Mar 28, 2025 3.30 Bn
Dec 31, 2024 3.08 Bn
Sep 27, 2024 3.17 Bn
Jun 28, 2024 3.13 Bn
Mar 29, 2024 3.12 Bn
Dec 31, 2023 2.94 Bn
Sep 29, 2023 2.84 Bn
Jun 30, 2023 2.86 Bn
Mar 31, 2023 2.87 Bn
Dec 31, 2022 2.79 Bn
Sep 30, 2022 2.74 Bn
Jul 1, 2022 2.76 Bn
Apr 1, 2022 2.61 Bn
Dec 31, 2021 2.58 Bn
Oct 1, 2021 2.35 Bn
Jul 2, 2021 2.36 Bn